ERBB2 and breast cancer: Both have antioxidant activity [59], while 1-acetoxypinoresinol dramatically reduces the expression of the human epidermal growth factor receptor 2 (HER2) and specifically induces apoptotic cell death in cultured HER2-positive breast cancer cells, with marginal effects against HER2-negative cells [60].